Have a personal or library account? Click to login
Clinical and serological study of human alveolar echinococcosis in Slovakia in relation to the outcome of chemotherapy Cover

Clinical and serological study of human alveolar echinococcosis in Slovakia in relation to the outcome of chemotherapy

Helminthologia
Volume 43 (2006): Issue 4 (December 2006)
By: J. Kinčeková,  G. Hrčková,  H. Auer,  M. Szilágyiová,  J. Hudačková,  M. Stanislayová,  H. Poláček and  K. Šimeková  
Open Access
|Dec 2006

References

  1. [1] Amman, R. W., Eckert, J. (1996): Echinococcus. In Weinstock, J. V. (Ed): Parasitic diseases of the liver and intestines. Saunders, Philadelphia, pp 655–689
    Search in Google Scholar
  2. [2] Amman, R. W., Ilitsch, A., Marincek, B., Freiburghaus, A. U. (1994): Effect of chemotherapy on the larval mass and the long — term course of alveolar echinococcosis. Swiss Echinococcosis Study Group. Hepatology, 19: 735–742 10.1002/hep.1840190328
    Search in Google Scholar
  3. [3] Bresson-Hadni, S., Vuitton, D. A., Bartholomot, B., Godart, D., Meyer, J. P., Hrusovsky, S., Becker, M. C., Miguet, J. P. (2000): A 20-year history of alveolar echinococcosis in humans. Analysis of a series of 117 patients from eastern France. Eur. J. Gastroenterol. Hepatol., 12: 327–336
    Search in Google Scholar
  4. [4] Craig, P. (2003): Echinococcus multilocularis. Curr. Opin. Infect. Dis., 16: 437–444 http://dx.doi.org/10.1097/00001432-200310000-0001010.1097/00001432-200310000-00010
    Search in Google Scholar
  5. [5] Dayan, A. D. (2003): Albendazole, mebendazole and praziquantel. Review of non-clinical toxicity and pharmacokinetics. Acta Tropica., 86: 141–159 http://dx.doi.org/10.1016/S0001-706X(03)00031-710.1016/S0001-706X(03)00031-7
    Search in Google Scholar
  6. [6] Didier, D., Weiler, S., Rohmer, P., Lassegue, A., Deschamps, J.-P., Vuitton, D., Miguet, J. P., Weill, F. (1985): Hepatic alveolar echinococcosis: Correlative US and CT study. Radiology, 154: 179–186 10.1148/radiology.154.1.3880602
    Search in Google Scholar
  7. [7] Eckert, J., Amman, R. W. (1995): Clinical diagnosis and treatment of echinococcosis in human. In Thompson, R. C. A., Lymbery, A. J., (Eds): Echinococcus and hydatid disease. Wallingford: CAB International, pp 411–463
    Search in Google Scholar
  8. [8] Eckert, J., Deplazes, P. (1999): Alveolar echinococcosis in humans: the current situation in Central Europe and the need for countermeasures. Parasitol. Today, 15: 315–319 http://dx.doi.org/10.1016/S0169-4758(99)01476-310.1016/S0169-4758(99)01476-3
    Search in Google Scholar
  9. [9] Eckert, J., Gottstein, B., Heath, D., Liu, F. J. (2001): Prevention of echinococcosis in humans and safety precations. In Eckert, J., Gemmel, M. A., Meslin, F. X., Pawlowski, Z. S. (Eds): WHO/OIE Manual on Echinococcosis in humans and animals: a public health problem of global concern. Paris: WHO and OIE, pp 238–247
    Search in Google Scholar
  10. [10] Giraudoux, P., Raoul, F., Bardonnet, K., Vuillaume, P., Tourneux, F., Cliquet, F., Dellatre, R., Vuitton, D.-A. (2001): Alveolar echinococcosis: characteristics of a possible emergence and new perspectives in epidemiosurveillance. Méd. Mal. Infect., 31: 247–256 http://dx.doi.org/10.1016/S0399-077X(01)80065-210.1016/S0399-077X(01)80065-2
    Search in Google Scholar
  11. [11] Gottstein, B., Tschudi, K., Eckert, J., Ammann, R. (1989): Em2-ELISA for the follow-up of alveolar echinococcosis after complete surgical resection of liver lesions. Trans. Royal Soc. Trop. Med. Hyg., 83: 389–393 http://dx.doi.org/10.1016/0035-9203(89)90512-910.1016/0035-9203(89)90512-9
    Search in Google Scholar
  12. [12] Hattingen, J., Uerlings, A., Jaussi, R. (1996): Alveoläre Echinokokkose der Leber mit Lymfogener pulmonaler und zerebraler Metastasierung. Forschr Rontgenstr, 1: 91–94 http://dx.doi.org/10.1055/s-2007-101572110.1055/s-2007-1015721
    Search in Google Scholar
  13. [13] Ishizu, H., Uchino, J., Sato, N., Aoki, S., Suzuki, K., Kuribayashi, H. (1997): Effect of albendazole on recurrent and residual alveolar echinococcosis of the liver after surgery. Hepatology, 25: 528–531 http://dx.doi.org/10.1002/hep.51025030510.1002/hep.510250305
    Search in Google Scholar
  14. [14] Ito, A., Schantz, P. M., Wilson, J. F. (1995): Em18, a new serodiagnostic marker for differentiation of active and inactive cases in alveolar hydatid disease. A. J. Trop. Med. Hyg., 52: 41–44
    Search in Google Scholar
  15. [15] Kern, P., Bardonnet, K., Renner, E., Auer, H., Pawlowski, Z., Amman, R. W., Vuiton, D. A., Kern, P. (2003): European Echinococcosis Registry: human alveolar echinococcosis, Europe. 1982–2000. Emer. Inf. Dis., 9: 343–349
    Search in Google Scholar
  16. [16] Kinčeková, J., Auer, H., Reiterová, K., Dubinský, P., Szilágyiová, M., Lauko, L’, Aspöck, H. (2001): The first case of autochthonous human alveolar echinococcosis in the Slovak Republic. Mitt. Österr. Ges. Tropenmed. Parasitol., 23: 33–38
    Search in Google Scholar
  17. [17] Kinčeková, J., Reiterová, K., Dubinský, P., Szilágyiová, M., Johanes, R., Gottas, M. (2002): A second case of autochthonous human alveolar echinococcosis in the Slovak Republic. Helminthologia, 39: 193–196
    Search in Google Scholar
  18. [18] Lucius, R., Bilger, B. (1995): Echinococcus multilocularis in Germany: Increased awarenes or spreading of a parasite? Parasitol. Today, 11: 430–434 http://dx.doi.org/10.1016/0169-4758(95)80030-110.1016/0169-4758(95)80030-1
    Search in Google Scholar
  19. [19] Matossian, R. M., Awar, G. N., Radwan, H., Craig, P. S., Meshefedjian, G. A. (1992): Immune status during albendazole therapy for hydatidosis. Annals Trop. Med. Parasitol., 86: 67–75
    Search in Google Scholar
  20. [20] Miguet, J. P., Monange, C., Carbillet, J. P. (1976): L’échinococcose alvéolaire du foie. A propos de 20 cas observés en Franche-Comté. Etude anatomo-pathologique. Arch. Fr. Mal. Appl. Dig., 65: 23–32
    Search in Google Scholar
  21. [21] Rawden, H. C., Kokwaro, G. O., Ward, S. A., Edwards, G. (2000): Relative contribution of cytochromes P450 and flavin-containing monoxygenases to the metabolism of albendazole by human liver microsomes. Br. J. Clin. Pharmamacol., 49: 313–322 http://dx.doi.org/10.1046/j.1365-2125.2000.00170.x10.1046/j.1365-2125.2000.00170.x
    Search in Google Scholar
  22. [22] Reuter, S., Jensen, B., Buttenschoen, K., Kratzer, W., Kern, P. (2000): Benzimidazoles in the treatment of alveolar echinococcosis: a comparative study and review of the literature. J. Antimicrob. Chemother., 46: 451–456 http://dx.doi.org/10.1093/jac/46.3.45110.1093/jac/46.3.451
    Search in Google Scholar
  23. [23] Reuter, S., Nussle, K., Kolokythas, O., Hang, U., Rieber, A., Kern, P., Kratzer, W. (2001): Alveolar liver echinococcosis: A comparative study of three imaging techniques. Infection, 29: 119–125 http://dx.doi.org/10.1007/s15010-001-1081-210.1007/s15010-001-1081-2
    Search in Google Scholar
  24. [24] Reuter, S., Schirrmeister, H., Kratzer, W., Dreweck, C., Reske, S. N., Kern, P. (1999): Pericystic metabolic activity in alveolar echinococcosis: Assessment and follow-up by positron emission tomography. Clin. Inf. Dis., 29: 1157–1163 http://dx.doi.org/10.1086/31343810.1086/313438
    Search in Google Scholar
  25. [25] Rigano, R., Profumo, E., Ioppolo, S., Notargiacomo, S., Ortona, E., Teggi, A., Siracusano, A. (1995): Immunological markers indicating the effectiveness of pharmacological treatment in human hydatid disease. Clin. Exp. Immunol., 102: 281–285 http://dx.doi.org/10.1111/j.1365-2249.1995.tb03778.x10.1111/j.1365-2249.1995.tb03778.x
    Search in Google Scholar
  26. [26] Short, J. A., Heiner, D. C., Hsiao, R. L., Andersen, F. L. (1990): Immunoglobulin E and G4 antibodies in cysticercosis. J. Clin. Microbiol., 28: 1635–1639
    Search in Google Scholar
  27. [27] Stanley, R. J. (1983): Liver and biliary tract. In Lee, J. K. T., Sagel, S. S., Stanley, R. J. (Eds): Computed Body Tomography. New York, Raven Press, pp 167–211
    Search in Google Scholar
  28. [28] Šlais, J., Madle, A., Vanka, K., Jelínek, F., Černik, M., Průchova, M., Jindra, J. (1979): Alveolar hydatidosis (echinococcosis) diagnosis by liver puncture biopsy. Čas. lék. čes., 15: 472–476
    Search in Google Scholar
  29. [29] Wen, H., Bresson-Hadni, S., Vuiton, D. A., Lenys, D., Yang, B. M., Ding, Z. X., Craig, P. S. (1995): Analysis of immunoglobulin G subclass in the serum antibody response of alveolar echinococcosis patients after surgical treatment and chemotherapy as an aid to assessing the outcome. Trans. Royal Soc. Trop. Med. Hyg., 89: 692–697 http://dx.doi.org/10.1016/0035-9203(95)90449-210.1016/0035-9203(95)90449-2
    Search in Google Scholar
  30. [30] Wen, H., Craig, P. S. (1994): Immunoglobulin G subclass responses in human cystic and alveolar echinococcosis. Annals Trop. Med. Hyg., 51: 741–748
    Search in Google Scholar
  31. [31] World Health Organisation (1996): Guidelines for treatment of cystic and alveolar echinococcosis in humans. Bulletin of the World Health Organisation, 74: 231–242
    Search in Google Scholar
DOI: https://doi.org/10.2478/s11687-006-0040-y | Journal eISSN: 1336-9083 | Journal ISSN: 0440-6605
Journal RSS Feed
Language: English
Page range: 213 - 219
Published on: Dec 1, 2006
Published by: Slovak Academy of Sciences, Institute of Parasitology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Echinococcus multilocularis,
CT imaging,
chemotherapy,
serology
Related subjects:
Life sciences,
Zoology,
Ecology,
Life sciences, other,
Medicine,
Clinical medicine,
Microbiology, virology and infection epidemiology

© 2006 J. Kinčeková, G. Hrčková, H. Auer, M. Szilágyiová, J. Hudačková, M. Stanislayová, H. Poláček, K. Šimeková, published by Slovak Academy of Sciences, Institute of Parasitology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 43 (2006): Issue 4 (December 2006)Next article